These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34443554)

  • 1. The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis.
    García-Arellano S; Hernández-Palma LA; Cerpa-Cruz S; Sánchez-Zuno GA; Herrera-Godina MG; Muñoz-Valle JF
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
    Hernández-Palma LA; García-Arellano S; Bucala R; Llamas-Covarrubias MA; De la Cruz-Mosso U; Oregon-Romero E; Cerpa-Cruz S; Parra-Rojas I; Plascencia-Hernández A; Muñoz-Valle JF
    Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
    García-Arellano S; Hernández-Palma LA; Bucala R; Hernández-Bello J; De la Cruz-Mosso U; García-Iglesias T; Cerpa-Cruz S; Padilla-Gutiérrez JR; Valle Y; Soñanez-Organis JG; Parra-Rojas I; Pereira-Suárez AL; Muñoz-Valle JF
    Curr Mol Med; 2018; 18(10):679-688. PubMed ID: 30698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
    Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
    Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Transcriptional Factors of T Helper Differentiation (T-bet, GATA-3, RORγt, and FOXP3), MIF Receptors (CD44, CD74, CXCR2, 4, 7), and Th1, Th2, and Th17 Cytokines in PBMC from Control Subjects and Rheumatoid Arthritis Patients.
    Zerpa-Hernández DA; García-Chagollán M; Sánchez-Zuno GA; García-Arellano S; Hernández-Bello J; Hernández-Palma LA; Cerpa-Cruz S; Martinez-Bonilla G; Nicoletti F; Muñoz-Valle JF
    Curr Mol Med; 2024; 24(9):1169-1182. PubMed ID: 37807647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis.
    Chovanova L; Vlcek M; Krskova K; Penesova A; Radikova Z; Rovensky J; Cholujova D; Sedlak J; Imrich R
    Gen Physiol Biophys; 2013 Sep; 32(3):395-404. PubMed ID: 23817641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
    Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
    Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
    Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
    Kim KW; Kim HR
    Korean J Intern Med; 2016 Jul; 31(4):634-42. PubMed ID: 27169879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Li X; Lei Y; Gao Z; Zhang B; Xia L; Lu J; Shen H
    Sci Rep; 2020 Dec; 10(1):22239. PubMed ID: 33335239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.
    Bottomley MJ; Webb NJ; Watson CJ; Holt PJ; Freemont AJ; Brenchley PE
    Clin Exp Immunol; 1999 Jul; 117(1):171-6. PubMed ID: 10403932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-29 Enhances LPS/TLR4-Mediated Inflammation in Rheumatoid Arthritis.
    Xu D; Yan S; Wang H; Gu B; Sun K; Yang X; Sun B; Wang X
    Cell Physiol Biochem; 2015; 37(1):27-34. PubMed ID: 26278073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Park MK; Yoon CH; Park SH; Lee SH; Kim HY
    Arthritis Res Ther; 2005; 7(1):R139-48. PubMed ID: 15642134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
    Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
    Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
    Liu M; Xie Z; Sun G; Chen L; Qi D; Zhang H; Xiong J; Furey A; Rahman P; Lei G; Zhai G
    Arthritis Res Ther; 2021 Feb; 23(1):59. PubMed ID: 33610191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
    Santoscoy-Ascencio G; Baños-Hernández CJ; Navarro-Zarza JE; Hernández-Bello J; Bucala R; López-Quintero A; Valdés-Alvarado E; Parra-Rojas I; Illades-Aguiar B; Muñoz-Valle JF
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1037. PubMed ID: 31701681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.